{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:14:27Z","timestamp":1783484067563,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05197-5","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:33:57Z","timestamp":1778866437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stereotactic body radiotherapy and other locoregional therapies for hepatocellular carcinoma in patients with cirrhosis: real-world treatment allocation, BCLC-stratified outcomes, and prognostic determinants"],"prefix":"10.1007","volume":"17","author":[{"given":"Cyriac Abby","family":"Philips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tharun Tom","family":"Oommen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Sasidharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif Hussain","family":"Theruvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryalakshmi","family":"Sreemohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambily","family":"Baby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinu Mary","family":"Saji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Tharakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Augustine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"issue":"2","key":"5197_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3350\/cmh.2023.0070","volume":"29","author":"JH Oh","year":"2023","unstructured":"Oh JH, Jun DW. The latest global burden of liver cancer: A past and present threat. Clin Mol Hepatol. 2023;29(2):355\u20137. https:\/\/doi.org\/10.3350\/cmh.2023.0070.","journal-title":"Clin Mol Hepatol"},{"key":"5197_CR2","doi-asserted-by":"publisher","first-page":"1526206","DOI":"10.3389\/fonc.2025.1526206","volume":"15","author":"Z Ding","year":"2025","unstructured":"Ding Z, Wang L, Sun J, Zheng L, Tang Y, Tang H. Hepatocellular carcinoma: pathogenesis, molecular mechanisms, and treatment advances. Front Oncol. 2025;15:1526206. https:\/\/doi.org\/10.3389\/fonc.2025.1526206.","journal-title":"Front Oncol"},{"issue":"12","key":"5197_CR3","doi-asserted-by":"publisher","first-page":"100578","DOI":"10.1016\/j.jhepr.2022.100578","volume":"4","author":"M Allaire","year":"2022","unstructured":"Allaire M, Bruix J, Korenjak M, et al. What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association. JHEP Rep. 2022;4(12):100578. https:\/\/doi.org\/10.1016\/j.jhepr.2022.100578.","journal-title":"JHEP Rep"},{"issue":"3","key":"5197_CR4","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3390\/cancers16030666","volume":"16","author":"E Kinsey","year":"2024","unstructured":"Kinsey E, Lee HM. Management of Hepatocellular Carcinoma in 2024: The Multidisciplinary Paradigm in an Evolving Treatment Landscape. Cancers (Basel). 2024;16(3):666. https:\/\/doi.org\/10.3390\/cancers16030666.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5197_CR5","doi-asserted-by":"publisher","first-page":"102386","DOI":"10.1016\/j.jceh.2024.102386","volume":"15","author":"D Sharma","year":"2025","unstructured":"Sharma D, Khosla D, Meena BL, Yadav HP, Kapoor R. Exploring the Evolving Landscape of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma. J Clin Exp Hepatol. 2025;15(1):102386. https:\/\/doi.org\/10.1016\/j.jceh.2024.102386.","journal-title":"J Clin Exp Hepatol"},{"issue":"12","key":"5197_CR6","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s11864-022-01025-4","volume":"23","author":"KM Daniell","year":"2022","unstructured":"Daniell KM, Banson KM, Diamond BH, Sioshansi S. Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis. Curr Treat Options Oncol. 2022;23(12):1761\u201374. https:\/\/doi.org\/10.1007\/s11864-022-01025-4.","journal-title":"Curr Treat Options Oncol"},{"issue":"2","key":"5197_CR7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jhep.2012.03.004","volume":"57","author":"VW Keng","year":"2012","unstructured":"Keng VW, Largaespada DA, Villanueva A. Why men are at higher risk for hepatocellular carcinoma? J Hepatol. 2012;57(2):453\u20134. https:\/\/doi.org\/10.1016\/j.jhep.2012.03.004.","journal-title":"J Hepatol"},{"issue":"1","key":"5197_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.17998\/jlc.2025.02.28","volume":"25","author":"HA Lee","year":"2025","unstructured":"Lee HA. Management of hepatocellular carcinoma in elderly and adolescent\/young adult populations. J Liver Cancer. 2025;25(1):52\u201366. https:\/\/doi.org\/10.17998\/jlc.2025.02.28.","journal-title":"J Liver Cancer"},{"issue":"1","key":"5197_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3350\/cmh.2022.0095","volume":"29","author":"T Nakatsuka","year":"2023","unstructured":"Nakatsuka T, Tateishi R. Development and prognosis of hepatocellular carcinoma in patients with diabetes. Clin Mol Hepatol. 2023;29(1):51\u201364. https:\/\/doi.org\/10.3350\/cmh.2022.0095.","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"5197_CR10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3390\/cancers13020192","volume":"13","author":"LA P\u00e9rez-Romasanta","year":"2021","unstructured":"P\u00e9rez-Romasanta LA, Gonz\u00e1lez-Del Portillo E, Rodr\u00edguez-Guti\u00e9rrez A, Mat\u00edas-P\u00e9rez \u00c1. Stereotactic Radiotherapy for Hepatocellular Carcinoma, Radiosensitization Strategies and Radiation-Immunotherapy Combination. Cancers (Basel). 2021;13(2):192. https:\/\/doi.org\/10.3390\/cancers13020192.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"5197_CR11","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1200\/JCO-24-01532","volume":"43","author":"M Xi","year":"2025","unstructured":"Xi M, Yang Z, Hu L, et al. Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Recurrent Small Hepatocellular Carcinoma: A Randomized, Open-Label, Controlled Trial. J Clin Oncol. 2025;43(9):1073\u201382. https:\/\/doi.org\/10.1200\/JCO-24-01532.","journal-title":"J Clin Oncol"},{"issue":"13","key":"5197_CR12","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","volume":"31","author":"A Bujold","year":"2013","unstructured":"Bujold A, Massey CA, Kim JJ, et al. Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol. 2013;31(13):1631\u20139. https:\/\/doi.org\/10.1200\/JCO.2012.44.1659.","journal-title":"J Clin Oncol"},{"issue":"24","key":"5197_CR13","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1200\/JCO.2018.78.6012","volume":"36","author":"A Shinde","year":"2018","unstructured":"Shinde A, Jones BL, Chen YJ, Amini A. Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma: Does Radiation Dose Make a Difference? J Clin Oncol. 2018;36(24):2566\u20137. https:\/\/doi.org\/10.1200\/JCO.2018.78.6012.","journal-title":"J Clin Oncol"},{"issue":"3","key":"5197_CR14","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00432-020-03389-2","volume":"147","author":"M Loi","year":"2021","unstructured":"Loi M, Comito T, Franzese C, et al. Stereotactic body radiotherapy in hepatocellular carcinoma: patient selection and predictors of outcome and toxicity. J Cancer Res Clin Oncol. 2021;147(3):927\u201336. https:\/\/doi.org\/10.1007\/s00432-020-03389-2.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"5197_CR15","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1080\/02656736.2020.1843719","volume":"37","author":"L Wang","year":"2020","unstructured":"Wang L, Ke Q, Huang Q, Shao L, Chen J, Wu J. Stereotactic body radiotherapy versus radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperth. 2020;37(1):1313\u201321. https:\/\/doi.org\/10.1080\/02656736.2020.1843719.","journal-title":"Int J Hyperth"},{"issue":"11","key":"5197_CR16","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1097\/MEG.0000000000002442","volume":"34","author":"HS Shin","year":"2022","unstructured":"Shin HS, Hwan Lee S, Jun BG, et al. Stereotactic body radiotherapy versus radiofrequency ablation as initial treatment of small hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2022;34(11):1187\u201394. https:\/\/doi.org\/10.1097\/MEG.0000000000002442.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"12","key":"5197_CR17","doi-asserted-by":"publisher","first-page":"6815","DOI":"10.21873\/anticanres.13054","volume":"38","author":"V Valakh","year":"2018","unstructured":"Valakh V, Gresswell S, Kirichenko A. Outcomes of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma with Severe Cirrhosis and Ineligibility for Transplant. Anticancer Res. 2018;38(12):6815\u201320. https:\/\/doi.org\/10.21873\/anticanres.13054.","journal-title":"Anticancer Res"},{"issue":"2","key":"5197_CR18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamaoncol.2024.5403","volume":"11","author":"LA Dawson","year":"2025","unstructured":"Dawson LA, Winter KA, Knox JJ, et al. Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma: The NRG Oncology\/RTOG 1112 Phase 3 Randomized Clinical Trial. JAMA Oncol. 2025;11(2):136\u201344. https:\/\/doi.org\/10.1001\/jamaoncol.2024.5403.","journal-title":"JAMA Oncol"},{"issue":"11","key":"5197_CR19","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00066-019-01462-5","volume":"195","author":"HK Byun","year":"2019","unstructured":"Byun HK, Kim N, Park S, Seong J. Acute severe lymphopenia by radiotherapy is associated with reduced overall survival in hepatocellular carcinoma. Strahlenther Onkol. 2019;195(11):1007\u201317. https:\/\/doi.org\/10.1007\/s00066-019-01462-5.","journal-title":"Strahlenther Onkol"},{"key":"5197_CR20","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3389\/fonc.2019.00896","volume":"9","author":"Y Zhuang","year":"2019","unstructured":"Zhuang Y, Yuan BY, Chen GW, et al. Association Between Circulating Lymphocyte Populations and Outcome After Stereotactic Body Radiation Therapy in Patients with Hepatocellular Carcinoma. Front Oncol. 2019;9:896. https:\/\/doi.org\/10.3389\/fonc.2019.00896.","journal-title":"Front Oncol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05197-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05197-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05197-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:24:57Z","timestamp":1783481097000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05197-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5197"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05197-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments. The study protocol was approved by the Institutional Ethics Committee of Rajagiri Hospital, Aluva, Kerala, India.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The requirement for written informed consent was waived by the Institutional Ethics Committee of Rajagiri Hospital, Aluva, Kerala, India, due to the retrospective nature of the study and the use of anonymized data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1000"}}